Apellis and Sobi Enter Collaboration for Global Co-development and Ex-US Commercialization of…
Apellis Pharmaceuticals, Inc. and Swedish Orphan Biovitrum AB (publ) announced a strategic collaboration to accelerate the advancement of systemic pegcetacoplan, a targeted C3 therapy,…
Read More...
Read More...
